11:00 a.m. –12:45 p.m. Registration
Bayside Foyer (Level 1)

12:00 –12:45 p.m. Lunch
Oceanside A (Level 2)

​

What is Eyecelerator?
David W. Parke II, MD, Steve Speares and Gil Kliman, MD 

​

Conference Overview

Eric D. Donnenfeld, MD and Jim Mazzo

​

Take a peek behind the investment banking curtain for a critical assessment of today's shifting health care markets.

​

A panel of global strategic executives examines the impact of COVID-19 on ophthalmic companies and where they'll focus resources in the coming years.  

Moderator: Richard L. Lindstrom, MD
 

Aerie: Tom Mitro, President and Chief Operating Officer

Alcon: David Endicott, Chief Executive Officer

BVI: Shervin Korangy, President & CEO

Glaukos: Chris Calcaterrra, COO

Zeiss: Euan Thomson, President Ophthalmic Devices and Head of Digital

​

Get an informed perspective on the challenges and opportunities surrounding industry consolidation from a variety of viewpoints, including hospitals, private practice, CMS and equity investments. 

​

Moderator: Kerry Solomon, MD

Panelists:

Hospital: Rick Gannotta, DHA, FACHE

Private Practice: Ruth D. Williams, MD

Private Equity: Anthony Hayes

CMS Specialist/Reimbursements: Joel V. Brill, MD

​

We are on the cusp of pharmacologic treatments for presbyopia and competition is heating up.  So put down your readers and join us for a look at the companies innovating in one of the world's largest ophthalmic markets. 

​

Moderator: John P. Berdahl, MD

Panelists:

Preeya K. Gupta, MD

John A. Hovanesian, MD

Gil Kliman, MD

Vance Thompson, MD
 

Company Showcases

1. Allergan, an AbbVie Co.: Michael R. Robinson, MD

2. Eyenovia, Inc.: Michael Rowe

3. Ocuphire Pharma: Mina Sooch

4. Orasis Pharmaceutical: Elad Kedar

5. LENZ Therapeutics: Eef Schimmelpennink

6. Visus Therapeutics, Inc.: Ben Bergo

Enjoy refreshments and connect with your colleagues.

​

​

Dry Eye: The Need For Innovation

Dry eye represents one of the biggest unmet needs in eye care. Hear from the innovation companies developing new treatments with a variety of MOAs.

Moderator: Edward J. Holland, MD

Panelists:

Robert Dempsey

Marjan Farid, MD

Nicole R. Fram, MD

Francis S. Mah, MD

​

Company Showcases​

1. Allegro Ophthalmics, LLC: Vicken Karageozian, MD

2. Azura Ophthalmics: Charles Bosworth, PhD

3. Oculis: Riad Sherif, MD

4. Oyster Point Pharma: Jeffrey Nau, PhD, MMS

5. Palatin: Carl Spana, PhD

6. Surface Ophthalmics, Inc.: Kamran Hosseini, MD, PhD

7. Tarsus Pharmaceuticals: Aziz Mottiwala

A panel of global strategic executives examines the impact of COVID-19 on ophthalmic companies and where they'll focus resources in the coming years.  

Moderator: Cathleen M. McCabe, MD

​

• Allergan, an AbbVie Company: Jag Dosanjh, SR. VP, Specialty Therapeutics

• Bausch Health Joseph Papa, Chief Executive Officer

• Johnson & Johnson: Warren Foust, Worldwide President, Surgical

• STAAR Surgical: Caren Mason, President & CEO

​

Meet the companies pioneering innovative new treatments within the specialty. 

​

Moderators: Nathan M. Radcliffe, MD and Thomas W. Samuelson, MD

​

Panelists:  

Ron Bache

Leon Herndon, MD

Sarah Van Tassel, MD

Robert Warner

​

Company Showcases​

1. Avisi Technologies: Rui Jing Jiang

2. ELT Sight, Inc.: Matilda Parente, MD, FCAP

3. Equinox:  John P. Berdahl, MD

4. ViaLase Inc.: Hadi Srass

​

Eric D. Donnenfeld, MD and Jim Mazzo

Moderator: Gil Kliman, MD

Panelists: Andy Corley, Ranya Habash, MD, Jeff Weinhuff

3:25 – 3:35 p.m.
LifeLong Vision: Ranya Habash, MD

Part 1: Next Gen Cataract/IOL Technology
 

3:35 – 3:45 p.m.

LensGen, Inc.: Sumit (Sam) Garg, MD
 

3:45 – 3:55 p.m.

JelliSee Ophthalmics, Inc.: Jim Ellis, MD
 

3:55 – 4:05 p.m.

Samsara Vision: Tom Ruggia
 

4:05 – 4:15 p.m.
Centricity Vision, Inc.: Rob Thornhill

Part 2: Uber-Tech Devices

​

4:15 – 4:25 p.m.
Keranova: Michael Brownell
 

4:25 – 4:35 p.m.

Eye-Yon Medical: Nahum Ferera
 

4:35 – 4:45 p.m.
Smartlens Inc.: Savas Komban

Part 3: Dry Eye Pharmacopoeia
 

4:45 – 4:55 p.m.
Aldeyra Therapeutics, Inc.: Todd Brady, MD, PhD

​

4:55 – 5:05 p.m.
Ocular Therapeutix: Michael Goldstein, MD
 

5:05 – 5:15 p.m.
TearSolutions: Anil Asrani
 

5:15 – 5:25 p.m.
Allysta Pharmaceuticals: Henry Hsu

​

Gil Kliman, MD

​

​

​